Skip to content
knowrare
HealthSignal
Your condition community

Living with Primary CD59 deficiency

A rare genetic condition starting in infancy that affects red blood cells, nerves and blood flow to the brain.

Understanding Primary CD59 deficiency

Primary CD59 deficiency is a rare genetic disease that affects the blood and the nervous system.

It causes long-lasting breakdown of red blood cells (hemolysis). It also causes early-onset, relapsing nerve inflammation and damage in the arms and legs (polyneuropathy) and one-time or repeated problems with blood flow to the brain (cerebrovascular events). It starts around birth or in infancy.

Signs & symptoms

GARD doesn't list a separate symptom list for this condition. Its description mentions these:

  • Long-lasting breakdown of red blood cells (hemolysis)
  • Relapsing nerve inflammation and damage in the arms and legs
  • Problems with blood flow to the brain (cerebrovascular events)

Not everyone has every symptom. GARD's list comes from the Human Phenotype Ontology.

Diagnosis

  1. Talk with your doctor

    Share the symptoms you've noticed, when they started and your family health history. Notes and photos can help.

  2. See a specialist

    Specialists who may be involved include allergy and immune system specialists, blood and bone marrow specialists, brain and nervous system specialists and genetic specialists.

  3. Consider genetic testing

    Changes in CD59 are linked to this condition. Genetic testing and counseling can help confirm a diagnosis and explain what it means for your family.

  4. Connect with expert centers

    The Foundation for Peripheral Neuropathy and Immune Deficiency Foundation may keep lists of experts for this condition.

Care & treatment

Care team
Allergy and immune system specialists (allergists / immunologists); Blood and bone marrow specialists (hematologists); Brain and nervous system specialists (neurologists); Genetic specialists (geneticists)
Expert care
Expert lists: The Foundation for Peripheral Neuropathy, Immune Deficiency Foundation
Treatment
GARD doesn't list specific treatments for this condition. Your care team will tailor care to your symptoms.
Research
Clinical trials and observational studies may be options. See the research section below.

General information, not medical advice. Your care team makes the decisions.

Everyday life

Living with a rare condition is easier with support.

  • Connect with The Foundation for Peripheral Neuropathy and other patient organizations
  • Keep notes on symptoms, changes and questions for appointments
  • Ask about patient registries that help research
  • Look into financial aid and travel resources for care visits
Bring these questions to your next doctor visit
Should we have genetic testing for CD59, and should siblings be tested?
Which specialists, such as hematology and neurology, should be involved?
How should we watch for new nerve or brain symptoms?

Quick facts

Symptoms usually startNewborn and as an Infant
InheritanceAutosomal Recessive
GenesCD59

Changes in the CD59 gene cause this condition. It is autosomal recessive, meaning a child inherits a changed copy of the gene from each parent.

GeneticNeurologicalBlood

Also known as: cd59-mediated hemolytic anemia with or without immune-mediated polyneuropathy; hemolytic anemia, cd59-mediated

Patient organizations

Source: NIH GARD · Primary CD59 deficiencyGARD ID 17054 · GARD page updated September 2026 · Plain-language summary by Know Rare; editorial review pending. General information, not medical advice.

You are more than your diagnosis

Perspectives from people navigating life with Primary CD59 deficiency.

Explore the Primary CD59 deficiency blog

Explore research for Primary CD59 deficiency

Explore actively recruiting Primary CD59 deficiency studies with HealthSpark.

HealthSpark

Find actively recruiting studies for Primary CD59 deficiency with HealthSpark. Share your city to explore research near you.

  • Recruiting studies from ClinicalTrials.gov
  • Share your city to look for research near you
  • Eligibility is confirmed by the study team

Powered by HealthSpark, our AI chat helper

I can help you find recruiting Primary CD59 deficiency studies. Enter a ZIP code, address or city below and I'll look within 50 miles.

Powered by HealthSpark, our AI chat helper · Study information from ClinicalTrials.gov · Eligibility is confirmed by the study team.

Get Signals for Primary CD59 deficiency

Stay in the loop with community stories and updates from medical researchers.

HealthStoryfor Primary CD59 deficiency

Create a living journal that talks back

HealthStory evolves private journaling with a living AI journal that talks back and asks thoughtful questions, helping you capture your Primary CD59 deficiency experiences more deeply and prepare for better conversations with your doctors and care team.

Start your journal

Your journal is private. Sharing your story publicly is a separate choice, made with Share your story above.